RAIDs - European project in cervical cancer : objectives
To identify prognostic and predictive biomarkers for standard and innovative therapies in cervical cancer patients using both high throughput genomic and proteomic approaches, the final aim being to improve treatment response for the individual patient;
To define a set of stratification criteria for therapy in patients with cervical cancer based on the tumour’s molecular profile;
To identify underlying mechanisms causing immune tolerance of this sexually transmitted viral disease in order to facilitate innovative clinical interventions by vaccination studies (together with micro-environment modulators and/or checkpoint inhibitors);
To improve clinical outcome of patients with cervical cancer by setting the ground for innovative interventional precision medicine trials in Europe.